Molecular mechanism by which Wnt5a affects clinical outcome in PCa is not yet fully understood, although it is likely that Wnt5a has an effect on invasion of tumor cells in PCa, as has been described in other malignancies [18, 27, 28]. This evidence concerns the gene WNT5A and neoplasm.